Vivos Therapeutics, Inc. (VVOS) Ownership
VVOS ownership summary
as of October 18, 2026- Institutions
- 3.9% of shares outstanding
- Insiders
- 11.32% of shares outstanding
- Shares outstanding
- 33.6M
- Float
- 19.1M shares available to trade
- Short interest
- 9.29% 2.9M shares short
- Days to cover
- 0.09 short interest up 76.1% vs prior month
- Institutions 3.89%
- Insiders 11.32%
- Other investors 84.79%
VVOS top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 0.25% | 85K | $11,135 | −10,542 (−11.0%) | June 30, 2026 |
| 2 | IHT Wealth Management, LLC | 0.23% | 77K | $10,052 | +35,675 (+86.9%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 0.18% | 61K | $7,942 | −212,700 (−77.8%) | June 30, 2026 |
| 4 | Commonwealth Equity Services, LLC | 0.13% | 42K | $5,568 | — | June 30, 2026 |
| 5 | UBS Group AG | 0.12% | 39K | $5,129 | +28,108 (+254.5%) | June 30, 2026 |
| 6 | National Asset Management Inc | 0.11% | 38K | $4,987 | — | June 30, 2026 |
| 7 | Centurion Wealth Management LLC | 0.11% | 36K | $4,675 | — | June 30, 2026 |
| 8 | BlackRock Inc | 0.08% | 28K | $3,644 | — | June 30, 2026 |
| 9 | State Street Corp | 0.07% | 25K | $3,265 | — | June 30, 2026 |
| 10 | Sequoia Financial Advisors LLC | 0.07% | 24K | $3,144 | — | June 30, 2026 |
| 11 | Vanguard Fiduciary Trust Co | 0.07% | 23K | $3,070 | −7,400 (−24.0%) | June 30, 2026 |
| 12 | Northern Trust Corp | 0.06% | 21K | $2,722 | +8,264 (+66.1%) | June 30, 2026 |
| 13 | Acorn Wealth Advisors, LLC | 0.04% | 15K | $1,936 | — | June 30, 2026 |
| 14 | Susquehanna International Group, LLP | 0.03% | 10K | $1,320 | +10,075 (0.0%) | June 30, 2026 |
| 15 | Tower Research Capital LLC | 0.02% | 5,211 | $683 | −2,177 (−29.5%) | June 30, 2026 |
| 16 | Advisor Group Holdings, Inc. | <0.01% | 1,143 | $150 | — | June 30, 2026 |
| 17 | SignatureFD, LLC | <0.01% | 547 | $72 | — | June 30, 2026 |
| 18 | Integrated Wealth Concepts LLC | <0.01% | 320 | $42 | +320 (0.0%) | June 30, 2026 |
| 19 | Ronald Blue Trust, Inc. | <0.01% | 160 | $21 | — | June 30, 2026 |
| 20 | Kozak & Associates, Inc. | <0.01% | 49 | $6 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 5 holders added 82K shares and 4 cut 233K.
VVOS top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.18% | 60K | $7,918 | −325 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Total Market Index | 0.04% | 12K | $1,581 | — | August 31, 2026 |
| 3 | Fidelity Series Total Market Index | 0.02% | 8,350 | $1,094 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VVOS insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-31 | Michael C Skaff | Buy | $1.34 | 1,353,625 | $1.8M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VVOS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VVOS
Institutional investors own 3.9% of Vivos Therapeutics's shares and insiders 11.32%. The largest holder is Geode Capital Management, LLC with 0.25% of the shares (85K), as of June 30, 2026. Among the top 20 institutions, 5 added shares and 4 reduced their stake in the latest filings. Short interest is 9.29% of the float, or 0.09 days of average trading volume. The share count rose 1,768.2% since 2019.
Related: VVOS analyst forecast, VVOS key metrics. See the VVOS stock overview for the latest quote and news.
VVOS ownership FAQ
Who owns the most Vivos Therapeutics stock?
The largest shareholders of Vivos Therapeutics are Geode Capital Management, LLC (0.25%), IHT Wealth Management, LLC (0.23%), Vanguard Capital Management, LLC (0.18%), Commonwealth Equity Services, LLC (0.13%), UBS Group AG (0.12%).
What percentage of Vivos Therapeutics is owned by institutions?
Institutions hold 3.9% of Vivos Therapeutics's shares outstanding; insiders hold 11.32%.
Which funds own Vivos Therapeutics?
The largest fund holders of Vivos Therapeutics are Fidelity Extended Market Index (0.18%), Fidelity Total Market Index (0.04%), Fidelity Series Total Market Index (0.02%).
What is Vivos Therapeutics's short interest?
2.9M shares of Vivos Therapeutics were sold short, 9.29% of the float; at the average daily volume it would take 0.09 days to cover.
Are insiders buying or selling Vivos Therapeutics?
Of the latest 1 reported insider transactions in Vivos Therapeutics (since March 31, 2026), 1 were purchases and 0 were sales.
How many shares of Vivos Therapeutics are outstanding?
Vivos Therapeutics has 33.6M shares outstanding, of which 19.1M are in the public float.